Which of the following describes the rationale for administering vitamin K to every neonate A.Neonates don't receive the clotting factor in utero.
B.The neonate lacks intestinal flora to make the vitamin. C.It boosts the minimal level of vitamin K found in the neonate. D.The drug prevents the development of phenylketonuria (PKU).